Listed below are the companies selected to present at the BIO CEO & Investor Conference.
The list is subject to change and will be updated periodically as selected companies confirm their presentations.
30-Minute Company Presentations
ACADIA Pharmaceuticals Inc. (NASDAQ : ACAD)
Acorda Therapeutics Inc. (NASDAQ : ACOR)
Acusphere, inc. (NASDAQ : ACUS)
ADVENTRX Pharmaceuticals, Inc. (AMEX : ANX)
Ęterna Zentaris Inc. (TSX : AEZ)
Affymax, Inc. (Nasdaq : AFFY)
Albany Molecular Research, Inc. (NASDAQ : AMRI)
Alexza Pharmaceuticals Inc. (NASDAQ : ALXA)
Alfacell Corporation (NASDAQ : ACEL)
Alkermes, Inc. (Nasdaq : ALKS)
Allon Therapeutics Inc. (TSX : NPC)
Alnylam Pharmaceuticals (NASDAQ : ALNY)
Ambrilia Biopharma Inc. (TSX : AMB)
Anadys Pharmaceuticals, Inc. (NASDAQ : ANDS)
Anesiva, Inc. (Nasdaq : ANSV)
Antisoma plc (London Stock Exchange : LSE:ASM)
Aradigm Corporation (OTCBB : ARDM)
Arena Pharmaceuticals, Inc. (NASDAQ : ARNA)
ArQule, Inc. (NASDAQ : ARQL)
Array BioPharma (NASDAQ : ARRY)
Avalon Pharmaceuticals (NASDAQ : AVRX)
AVANT Immunotherapeutics, Inc. (NASDAQ : AVAN)
Avicena Group (OTC.BB : AVGO)
BioCryst Pharmaceuticals, Inc. (NASDAQ : BCRX)
Bioenvision, Inc. (NASDAQ : BIVN)
BioMimetic Therapeutics, Inc. (NASDAQ : BMTI)
Biomira Inc. (NASDAQ : BIOM)
BioMS Medical Corp. (TSX : MS)
BioSante Pharmaceuticals (Amex : BPA)
Boston Life Sciences Inc. (NASDAQ : BLSI)
Cadence Pharmaceuticals, Inc. (NASDAQ : CADX)
Caliper Life Sciences (NASDAQ : CALP)
Callisto Pharmaceuticals, Inc. (Amex : KAL)
CELERA (NYSE : CRA)
Celgene Corporation (NASDAQ : CELG)
Cell Genesys, Inc. (NASDAQ : CEGE)
Cell Therapeutics, Inc. (Nasdaq : CTIC)
Cleveland BioLabs, Inc. (NASDAQ : CBLI)
CombinatoRx, Incorporated (NASDAQ : CRXX)
Cubist Pharmaceuticals, Inc. (NASDAQ : CBST)
CuraGen Corporation (NASDAQ : CRGN)
Cyclacel Pharmaceuticals, Inc. (NASDAQ : CYCC)
Cytogen Corporation (Nasdaq : CYTO)
Cytokinetics, Inc. (NASDAQ : CYTK)
CytRx Corporation (NASDAQ : CYTR)
deCODE genetics (DCGN)
Diversa Corporation (NASDAQ : DVSA)
DURECT Corporation (NASDAQ : DRRX)
Dyadic International, Inc (Amex : DIL)
Dyax Corp. (NASDAQ : DYAX)
Emergent BioSolutions Inc. (NYSE : EBS)
Emisphere Technologies, Inc. (NASDAQ : EMIS)
Encysive Pharmaceuticals Inc. (NASDAQ : ENCY)
EntreMed, Inc. (NASDAQ : ENMD)
EPIX Pharmaceuticals (NASDAQ : EPIX)
Evotec AG (FSE : EVT)
Exelixis, Inc. (NASDAQ : EXEL)
Forbes Medi-Tech Inc. (NASDAQ : FMTI)
Genfit (Alternext by Euronext : ALGFT)
Genomic Health, Inc. (NASDAQ : GHDX)
GenVec, Inc. (NASDAQ : GNVC)
Geron Corporation (NASDAQ : GERN)
GPC Biotech AG (Frankfurt : GPC)
GTC Biotherapeutics, Inc. (NASDAQ : GTCB)
GTx, Inc. (Nasdaq : GTXI)
Hana Biosciences (NASDAQ : HNAB)
Hollis-Eden Pharmaceuticals, Inc. (NASDAQ : HEPH)
Idera Pharmaceuticals, Inc. (AMEX : IDP)
ImmunoGen, Inc. (NASDAQ : IMGN)
Infinity Pharmaceuticals, Inc. (NASDAQ : INFI)
Inhibitex, Inc. (NASDAQ : INHX)
Innovive Pharmaceuticals (OTC BB : IVPH.OB)
Inovio Biomedical Inc. (AMEX : INO)
Introgen Therapeutics, Inc. (NASDAQ : INGN)
Iomai Corporation (NASDAQ : IOMI)
Jerini AG (Frankfurt : FI4)
Keryx Biopharmaceuticals, Inc. (NASDAQ : KERX)
Kosan Biosciences (Nasdaq : KOSN)
La Jolla Pharmaceutical Company (Nasdaq : LJPC)
MacroChem Corporation (OTC:BB : MACM.OB)
Medarex, Inc. (Nasdaq : MEDX)
Medicure Inc (Amex : MCU)
MediGene AG (Prime Standard : MDG)
Medivation, Inc. (AMEX : MDV)
MedX Health Corp. (Canadian OTC : MEDH)
Memory Pharmaceuticals (NASDAQ : MEMY)
Metabasis Therapeutics, Inc. (NASDAQ : MBRX)
MethylGene Inc. (TSX : MYG)
Micromet, Inc. (NASDAQ : MITI)
Millennium Pharmaceuticals, Inc. (NASDAQ : MLNM)
Momenta Pharmaceuticals, Inc. (NASDAQ : MNTA)
MorphoSys AG (FSE (Germany) : MOR GR)
Nabi Biopharmaceuticals (NASDAQ : NABI)
Nastech Pharmaceutical Company Inc. (NASDAQ : NSTK)
Neurogen Corporation (NASDAQ : NRGN)
Newron Pharmaceuticals SpA (SWX : NWRN)
Northfield Laboratories Inc. (Nasdaq : NFLD)
NovaDel Pharma (AMEX : NVD)
Novavax, inc. (NASDAQ : NVAX)
Novozymes North America, Inc (Danish OMX : NZYM B)
Nuvelo, Inc. (NASDAQ : NUVO)
Onyx Pharmaceuticals, Inc. (NASDAQ : ONXX)
Oxford BioMedica (London : OXB)
Palatin Technologies, Inc. (AMEX : PTN)
Panacos Pharmaceuticals Inc. (NASDAQ : PANC)
Peregrine Pharmaceuticals, Inc. (NASDAQ : PPHM)
Pharmacopeia (Nasdaq : PCOP)
Pharmaxis Ltd (ASX : PXS)
Poniard Pharmaceuticals (NASDAQ : PARD)
Renovis, Inc. (NASDAQ : RNVS)
Replidyne, Inc. (NASDAQ : RDYN)
Resverlogix (TSX : RVX)
Rigel Pharmaceuticals, Inc. (NASDAQ : RIGL)
Sangamo BioSciences, Inc. (NASDAQ : SGMO)
Santhera Pharmaceuticals AG (SWX : SANN)
SciClone Pharmaceuticals, Inc. (NASDAQ : SCLN)
Seattle Genetics, Inc. (NASDAQ : SGEN)
Sequenom (Nasdaq : SQNM)
SGX Pharmaceuticals, Inc. (NASDAQ : SGXP)
Spectrum Pharmaceuticals (Nasdaq : SPPI)
SuperGen, Inc. (NASDAQ : SUPG)
SyntheMed Inc. (OTCBB : SYMD)
Targacept, Inc. (NASDAQ : TRGT)
Targeted Genetics Corporation (NASDAQ : TGEN)
Vertex Pharmaceuticals Incorporated (NASDAQ : VRTX)
ViaCell, Inc. (Nasdaq : VIAC)
Vical Incorporated (NASDAQ : VICL)
VioQuest Pharmaceuticals, Inc. (OTC : VQPH)
Viragen, Inc. (Amex : VRA)
VIROPHARMA INCORPORATED (NASDAQ : VPHM)
VIVUS, Inc. (NASDAQ : VVUS)
XOMA (Nasdaq : XOMA)
XTL Biopharmaceuticals Ltd (Nasdaq : XTLB)
YM BioSciences Inc. (TSX : YM)
ZIOPHARM Oncology, Inc (NASDAQ : ZIOP)
ZymoGenetics Inc. (NASDAQ : ZGEN)